Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Hepatitis B | Research article

Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs – a single Centre retrospective cohort study in Denmark

Authors: Sara Thønnings, Filip Jansåker, Christoffer Sundqvist, Rebekka Faber Thudium, Susanne Dam Nielsen, Jenny Dahl Knudsen

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

People who inject drugs (PWID) have increased risk of acquiring blood-transmitted chronic viral infections such as Hepatitis B (HBV), Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) as well as increased risk of acquiring bacterial infections. We aimed to identify and describe bacteraemic episodes, their recurrence rates, predictive and prognostic factors amongst hospitalised PWID.

Methods

In this retrospective cohort study, we included 257 hospitalised PWID during 2000–2006 with follow up at the Department of Infectious Diseases, Hvidovre Hospital, Denmark. Data collection included comorbidity (HBV-, HCV-, HIV-, and psychiatric comorbidities), social information (contact to an addiction treatment centre, homelessness), opioid substitution treatment (OST), treatment completion and microbiology findings. There was a 10-years follow-up regarding mortality.

Results

The study identified 257 patients classified as PWID. Of these, 58 (22.6%) had at least one episode of bacteraemia during their first hospital admission. Recurrence was found in 29 (50.0%) of the bacteraemia cases. Staphylococcus aureus was the dominant microorganism of both first and recurrent episodes with 24 (41.4%) and nine (31.4%) of cases, respectively. A psychiatric diagnose was significantly associated with a lower risk of bacteraemia in the multivariate analysis (OR: 0.29, [95%CI: 0.11–0.77], P = 0.01). Mortality was significantly higher in patients with bacteraemia (17.2% vs. 3.0%, P < 0.01, OR: 6.67 [95%CI: 2.33–20], P < 0.01).

Conclusions

In hospitalised PWID, bacteraemia was found in 22.6% and was associated with at higher mortality. The most common microorganism of bacteraemia was S. aureus. Psychiatric comorbidity was significantly associated with a lower risk of bacteraemia.
Appendix
Available only for authorised users
Literature
2.
go back to reference Scheidegger C, Zimmerli W. Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis. 1989;11:486–93.CrossRef Scheidegger C, Zimmerli W. Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis. 1989;11:486–93.CrossRef
3.
go back to reference Lavender TW, McCarron B. Acute infections in intravenous drug users. Clin Med J Royal Coll Phys London. 2013;13:511–3. Lavender TW, McCarron B. Acute infections in intravenous drug users. Clin Med J Royal Coll Phys London. 2013;13:511–3.
4.
go back to reference Palepu A, et al. Hospital utilization and costs in a cohort of injection drug users. C Can Med Assoc J. 2001;165:415. Palepu A, et al. Hospital utilization and costs in a cohort of injection drug users. C Can Med Assoc J. 2001;165:415.
5.
go back to reference Koch K, et al. Socioeconomic inequalities in risk of hospitalization for community-acquired bacteremia: a Danish population-based case-control study. Am J Epidemiol. 2014;179:1096–106.CrossRef Koch K, et al. Socioeconomic inequalities in risk of hospitalization for community-acquired bacteremia: a Danish population-based case-control study. Am J Epidemiol. 2014;179:1096–106.CrossRef
6.
go back to reference Aagaard T, et al. Long-term mortality after Staphylococcus aureus spondylodiscitis: a Danish nationwide population-based cohort study. J Inf Secur. 2014;69:252–8. Aagaard T, et al. Long-term mortality after Staphylococcus aureus spondylodiscitis: a Danish nationwide population-based cohort study. J Inf Secur. 2014;69:252–8.
7.
go back to reference Jensen US, et al. Recurrent bacteraemia: a 10-year regional population-based study of clinical and microbiological risk factors. J Inf Secur. 2010;60:191–9. Jensen US, et al. Recurrent bacteraemia: a 10-year regional population-based study of clinical and microbiological risk factors. J Inf Secur. 2010;60:191–9.
8.
go back to reference Degenhardt L, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Heal. 2017;5:e1192–207.CrossRef Degenhardt L, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Heal. 2017;5:e1192–207.CrossRef
9.
go back to reference Schmidt M, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.CrossRef Schmidt M, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.CrossRef
10.
go back to reference Murray, P. R. & American Society for Microbiology. Manual of clinical microbiology. (ASM Press, 1999). Murray, P. R. & American Society for Microbiology. Manual of clinical microbiology. (ASM Press, 1999).
11.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.CrossRef Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.CrossRef
12.
go back to reference Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.CrossRef Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.CrossRef
13.
go back to reference Laupland KB, Pasquill K, Parfitt EC, Naidu P, Steele L. Burden of community-onset bloodstream infections, Western interior, British Columbia, Canada. Epidemiol Infect. 2016;144:2440–6.CrossRef Laupland KB, Pasquill K, Parfitt EC, Naidu P, Steele L. Burden of community-onset bloodstream infections, Western interior, British Columbia, Canada. Epidemiol Infect. 2016;144:2440–6.CrossRef
14.
go back to reference Nielsen SL, et al. Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study. J Inf Secur. 2015;70:111–26. Nielsen SL, et al. Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study. J Inf Secur. 2015;70:111–26.
15.
go back to reference Capdevila JA, et al. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med. 1994;154:411–5.CrossRef Capdevila JA, et al. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med. 1994;154:411–5.CrossRef
16.
go back to reference Wiese L, et al. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia. J Inf Secur. 2013;67:199–205. Wiese L, et al. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia. J Inf Secur. 2013;67:199–205.
17.
go back to reference Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967;67:1–22.CrossRef Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967;67:1–22.CrossRef
18.
go back to reference Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993;119:1017–28.CrossRef Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993;119:1017–28.CrossRef
19.
go back to reference Summanen PH, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20:S279–82.CrossRef Summanen PH, et al. Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis. 1995;20:S279–82.CrossRef
20.
go back to reference Spijkerman IJB, Van Ameijden EJC, Mientjes GHC, Coutinho RA, Van Den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–54.CrossRef Spijkerman IJB, Van Ameijden EJC, Mientjes GHC, Coutinho RA, Van Den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–54.CrossRef
21.
go back to reference Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit medical center. II infectious endecarditis: A prospective comparative study. Rev Infect Dis. 1986;8:374–96.CrossRef Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit medical center. II infectious endecarditis: A prospective comparative study. Rev Infect Dis. 1986;8:374–96.CrossRef
22.
go back to reference Crane LR, Levine DP, Zervos MJ, Cummings G. Bacteremia in narcotic addicts at the detroit medical center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis. 1986;8:364–73.CrossRef Crane LR, Levine DP, Zervos MJ, Cummings G. Bacteremia in narcotic addicts at the detroit medical center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis. 1986;8:364–73.CrossRef
23.
go back to reference Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: risk factors and prevention stategies. Infection. 2004;32:163–9.CrossRef Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: risk factors and prevention stategies. Infection. 2004;32:163–9.CrossRef
24.
go back to reference Wilson J, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect. 2011;17:451–8.CrossRef Wilson J, et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect. 2011;17:451–8.CrossRef
25.
go back to reference Laupland KB, Gregson DB, Church DL, Ross T, Pitout JDD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008;14:1041–7.CrossRef Laupland KB, Gregson DB, Church DL, Ross T, Pitout JDD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008;14:1041–7.CrossRef
Metadata
Title
Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs – a single Centre retrospective cohort study in Denmark
Authors
Sara Thønnings
Filip Jansåker
Christoffer Sundqvist
Rebekka Faber Thudium
Susanne Dam Nielsen
Jenny Dahl Knudsen
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05357-0

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue